<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>19(10)</volume><submitter>Bouwknegt DG</submitter><pubmed_abstract>&lt;h4>Background and aims&lt;/h4>Inflammatory bowel disease (IBD) often coincides with pregnancy, and disease activity during pregnancy increases the risk of adverse outcomes. We aimed to determine how disease course before conception influences relapse risk during pregnancy, adjusting for established risk factors.&lt;h4>Methods&lt;/h4>In this multicenter, retrospective cohort study, we included adult women with IBD who were pregnant during treatment at one of three university hospitals between 2017 and 2022. Using generalized estimating equations, we evaluated associations between relapse during pregnancy and pre-conceptional flares, categorized into three time intervals. Analyses were adjusted for phenotype, disease duration, surgical history, biologic use, smoking, and assisted reproduction. Inter</pubmed_abstract><journal>Journal of Crohn's &amp; colitis</journal><pagination>jjaf176</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12640223</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>How long is long enough? Timing of pre-conceptional remission predicts relapse risk during pregnancy in IBD.</pubmed_title><pmcid>PMC12640223</pmcid><pubmed_authors>Hoekstra B</pubmed_authors><pubmed_authors>van Dop W</pubmed_authors><pubmed_authors>Pierik M</pubmed_authors><pubmed_authors>van der Woude CJ</pubmed_authors><pubmed_authors>de Vries A</pubmed_authors><pubmed_authors>Bodelier A</pubmed_authors><pubmed_authors>Lowenberg M</pubmed_authors><pubmed_authors>van der Marel S</pubmed_authors><pubmed_authors>de Jonge V</pubmed_authors><pubmed_authors>Derikx L</pubmed_authors><pubmed_authors>Voorneveld P</pubmed_authors><pubmed_authors>Bouwknegt DG</pubmed_authors><pubmed_authors>Mares W</pubmed_authors><pubmed_authors>Nissen L</pubmed_authors><pubmed_authors>Horjus C</pubmed_authors><pubmed_authors>Oostenburg L</pubmed_authors><pubmed_authors>Duijvestein M</pubmed_authors><pubmed_authors>Festen N</pubmed_authors><pubmed_authors>Tauber T</pubmed_authors><pubmed_authors>Jansen J</pubmed_authors><pubmed_authors>van der Meulen A</pubmed_authors><pubmed_authors>van Dop WA</pubmed_authors><pubmed_authors>van der Wouden EJ</pubmed_authors><pubmed_authors>Mujagic Z</pubmed_authors><pubmed_authors>Mensink P</pubmed_authors><pubmed_authors>van Es B</pubmed_authors><pubmed_authors>Fidder H</pubmed_authors><pubmed_authors>Romkens T</pubmed_authors><pubmed_authors>Donker HC</pubmed_authors><pubmed_authors>Goetgebuer R</pubmed_authors><pubmed_authors>Mahmmod N</pubmed_authors><pubmed_authors>Visschedijk MC</pubmed_authors><pubmed_authors>Smeets X</pubmed_authors><pubmed_authors>Dutch Initiative on Crohn and Colitis (ICC)</pubmed_authors><pubmed_authors>Jharap B</pubmed_authors><pubmed_authors>Groen H</pubmed_authors><pubmed_authors>West R</pubmed_authors><pubmed_authors>van der Voorn M</pubmed_authors><pubmed_authors>Dijkstra G</pubmed_authors><pubmed_authors>van Schaik F</pubmed_authors><pubmed_authors>Visschedijk M</pubmed_authors></additional><is_claimable>false</is_claimable><name>How long is long enough? Timing of pre-conceptional remission predicts relapse risk during pregnancy in IBD.</name><description>&lt;h4>Background and aims&lt;/h4>Inflammatory bowel disease (IBD) often coincides with pregnancy, and disease activity during pregnancy increases the risk of adverse outcomes. We aimed to determine how disease course before conception influences relapse risk during pregnancy, adjusting for established risk factors.&lt;h4>Methods&lt;/h4>In this multicenter, retrospective cohort study, we included adult women with IBD who were pregnant during treatment at one of three university hospitals between 2017 and 2022. Using generalized estimating equations, we evaluated associations between relapse during pregnancy and pre-conceptional flares, categorized into three time intervals. Analyses were adjusted for phenotype, disease duration, surgical history, biologic use, smoking, and assisted reproduction. Inter</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-05-21T03:16:54.736Z</modification><creation>2026-05-21T03:11:16.406Z</creation></dates><accession>S-EPMC12640223</accession><cross_references><pubmed>41081747</pubmed><doi>10.1093/ecco-jcc/jjaf176</doi></cross_references></HashMap>